US20030129238A1 - Edible MCC/PGA coating composition - Google Patents

Edible MCC/PGA coating composition Download PDF

Info

Publication number
US20030129238A1
US20030129238A1 US10/306,649 US30664902A US2003129238A1 US 20030129238 A1 US20030129238 A1 US 20030129238A1 US 30664902 A US30664902 A US 30664902A US 2003129238 A1 US2003129238 A1 US 2003129238A1
Authority
US
United States
Prior art keywords
coating composition
coating
weight
propylene glycol
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/306,649
Inventor
Michael Augello
Sheila Dell
Eric Bliefernich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/306,649 priority Critical patent/US20030129238A1/en
Publication of US20030129238A1 publication Critical patent/US20030129238A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Definitions

  • This invention relates to edible, hardenable coating compositions comprising microcrystalline cellulose (MCC), a film forming amount of propylene glycol alginate (PGA) and a strengthening polymer, optionally containing a plasticizer, a surface active agent, a filler, a coloring agent or a combination of such optional ingredients.
  • MCC microcrystalline cellulose
  • PGA propylene glycol alginate
  • the coatings of the present invention can be applied to pharmaceutical, including neutraceutical, and veterinary solid dosage forms, such solid substrates such as seeds, animal feed, fertilizers, pesticide tablets and granules, and also to confectionery and foods. They are readily dispersed in aqueous media, and, when applied as a coating, provide high lustre coatings, which do not retard or extend release of active ingredient from a coated substrate.
  • a pharmaceutical or veterinary tablet coating Another very important function of a pharmaceutical or veterinary tablet coating is to improve the integrity of the tablet itself. Uncoated tablets are often subject to being abraded or chipped, causing a loss of active ingredient in the process. More dramatically, they may break into two or more pieces. One measure of a useful coating is its ability to prevent any of these physical degradations of tablet structure. The effectiveness of a coating material to prevent abrading, chipping, or breakage of the tablet is determined by friability testing.
  • Confectionery and foods may be coated with a formulation to preserve the confection or food from deteriorating by contact with the oxygen and the moisture in the atmosphere. Coatings also can provide improved appearance and desirable organoleptic properties to the food as well as preventing loss of flavor.
  • Seeds may be coated to preserve the viability of the seeds by protecting against moisture. They may also be coated as a means for increasing particle size to facilitate mechanical planting.
  • a dye can be included in the coating formulation to identify the seeds as to quality, type, or some other designation.
  • a pesticide e.g., a fungicide
  • this coating must not decrease the viability of the seeds or interfere with germination when the seeds are planted in the soil.
  • Animal feed may be coated to improve its flowability, appearance and its resistance to powdering or dusting.
  • the coating may be formulated to include vitamins, hormones, antibiotics, or the like, to benefit the livestock which will consume the feed.
  • Fertilizers in either granular or tableted forms, may be coated to retain the integrity of the form and, especially, to protect the fertilizer from moisture which can cause agglomeration during storage, which could make rapid, even application to the soil difficult or inconvenient.
  • Coating of tableted pesticide formulations serves to maintain the integrity of the tablets or granules until they are placed in water where they rapidly disintegrate, forming a solution or slurry to be applied to the soil or plants.
  • a second, and equally important, function of the coatings on tablets containing pesticides is to prevent human contact with the pesticide, thereby increasing safety for those handling and applying the pesticide.
  • the film-former In the preparation of a coating formulation to be sprayed, the film-former is usually dissolved or dispersed in a solvent, for example, water, along with the other ingredients of the formulation.
  • a solvent for example, water
  • the coating formulation must frequently be prepared in advance of the time it is to be applied to the tablets. A common procedure is to prepare these coating formulations the day preceding the coating operation in order to assure adequate hydration of the polymers used in them.
  • a particular disadvantage of coatings based primarily on hydroxypropylmethylcellulose (HPMC) is that the coating may harden over time and therefore increase tablet disintegration times.
  • An increase in disintegration time delays the bioavailability of the active ingredient at least in proportion to the increase in disintegration time.
  • Many other agents commonly used in coating compositions are also known to delay release of pharmaceutical agents, such as enteric coatings which use polymeric film forming materials which are insoluble in water, or gastric fluid, some of these being specifically selected to by-pass both the stomach and small intestine and provide colonic release.
  • the coatings of this invention meet U.S. Pharmacopeia standards for rapid or immediate dissolution (U.S.P. monograph 23) of active ingredients from tablets or other solid dosage forms coated with them. They provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrates. Thus, they do not adversely impact or retard release of active ingredients from a substrate coated with them. Further, the coatings of this invention are readily dispersed and rapidly hydrated in aqueous media for application to a coating substrate, and provide elegant coatings which have all the benefits of coatings now in commercial use without the drawbacks that are common to them.
  • a coating composition which comprises a unique combination of materials specifically adapted for prompt release when placed in aqueous media or ingested.
  • the coating composition of the present invention comprises microcrystalline cellulose, a film forming amount of propylene glycol alginate and a strengthening polymer, and may additionally contain a plasticizer, a surface active agent, a filler, a coloring agent or combination of these additional ingredients. More specifically, the present invention provides a prompt release, edible, hardenable coating composition, as well as dry coatings and aqueous dispersions thereof and solid dosage forms coated therewith.
  • the term “edible” is intended to mean food grade materials which are approved by regulatory authorities for use in pharmaceutical or food applications.
  • the term “hardenable,” used to describe the coating compositions of this invention is intended to include only those coating compositions that are capable of being dried from an aqueous solution or dispersion thereof into a solid coating which resists abrasive forces, i.e. a hardened coating, as distinguished from those “enrobing” coatings on confections which set up into a soft coating that can be handled and packaged but which do not resist abrasive forces significantly.
  • immediate means that the coatings of this invention meet U.S. Pharmacopeia standards (U.S.P. monograph 23) for rapid or immediate dissolution of active ingredients from tablets or other solid dosage forms coated with them.
  • U.S. Pharmacopeia standards U.S.P. monograph 23
  • they provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrate. They do not, when placed in water or ingested, adversely impact or retard release or dissolution of tablets or other dosage forms coated with them.
  • Coatings made in accordance with the present invention are substantially or completely disintegrated and/or dissolved within less than 10 minutes after being ingested or placed in aqueous media.
  • microcrystalline cellulose simply blended with propylene glycol alginate, provides important film characteristics required to provide an elegant coating which is particularly useful in, for example, coating pharmaceutical and veterinary tablets, caplets, granules, and spheres which contain active ingredients which require release promptly after being placed in aqueous media or ingested.
  • Microcrystalline cellulose is a purified, partially depolymerized cellulose that is generally produced by treating a source of cellulose, preferably alpha cellulose in the form of a pulp from fibrous plants, with a mineral acid, preferably hydrochloric acid. The acid selectively attacks the less ordered regions of the cellulose polymer chain, thereby exposing and freeing the crystallite sites, forming the crystallite aggregates which constitute microcrystalline cellulose. These are then separated from the reaction mixture and washed to remove degraded by-products. The resulting wet mass, generally containing 40 to 60
  • a film forming amount of propylene glycol alginate may be in the range of about 10% to about 50%, more specifically about 12% to about 50%, by dry weight of the coating composition.
  • the propylene glycol alginate employed in the present invention may vary widely in viscosity.
  • a typical high viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 700 to 1800 mPa ⁇ s at 25° C., and is commercially available as Protonalg ester SD-LB, Pronova/FMC Corporation.
  • a typical low viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 20-30 mPs ⁇ s at 25° C., and is commercially available as Profoam®, Pronova/FMC Corporation.
  • High viscosity propylene glycol alginate is generally employed in a lower amount than that employed for low viscosity material, typically in the range of 10% to about 20% by dry weight of the coating composition, as illustrated in examples 1-6 below.
  • Use of substantially higher amounts of high viscosity propylene glycol alginate may result in coating solutions which are too viscous, tend to plug coating equipment, and may not flow sufficiently to form a satisfactory coating.
  • Low viscosity propylene glycol alginate conversely is generally used in a higher amount, typically in the range of 20% to 50% by dry weight of the coating composition, as illustrated in examples 7 through 30.
  • Propylene glycol alginate may be used in combination with other film forming materials, for example, carrageenan and cellulosic polymers such as HPMC and hydroxypropylcellulose.
  • Carrageenan preferably iota carrageenan
  • Carrageenan may suitably be employed as a multifunctional component in combination with propylene glycol alginate at a concentration in the range of about 3% to about 20% of the dry weight of the coating composition.
  • carrageenan When carrageenan is employed in the composition at a concentration in the range of about 3% to about 8%, it is believed to serve primarily to improve the gloss of the resulting coating, that is, as a gloss enhancer.
  • the weight ratio of propylene glycol alginate to carrageenan is suitably in the range of about 2:1 to about 10:1.
  • Carrageenan may also be used at a level above about 9%, for example, at a concentration in the range of about 9% to about 20%, more specifically in the range of 10% to about 15%. At these levels it is believed to serve not only to improve gloss of the coating, but also to contribute film forming properties and to contribute to the strength and integrity of the resulting film coating.
  • carrageenan may be viewed to function as a co-film-former or as a supplemental or secondary film-former in the coating compositions.
  • Such a weight ratio of propylene glycol alginate to carrageenan may be in the range of 2:1 to about 0.8:1.
  • propylene glycol alginate when the weight ratio of propylene glycol alginate to carrageenan is in the range of about 1.5:1 to about 2:1, propylene glycol alginate may be considered to be the primary film-former and carrageenan the secondary film-former, as illustrated in examples 18 through 21 and 25 through 30.
  • propylene glycol alginate and carrageenan when approximately equal amounts of propylene glycol alginate and carrageenan are employed, that is, when the propylene glycol alginate to carrageenan weight ratio is, for example, in the range of about 1:0.8 to about 1:1.2, each of them may be considered to contribute relatively equal film forming properties to the resulting film coating, thus are considered to be co-film-formers as illustrated by examples 18 and 20-24.
  • the weight ratio of microcrystalline cellulose to propylene glycol alginate in the compositions of this invention may vary depending on the application, but generally range from about 90:10 to about 20:80, more specifically from about 80:20 to about 20:80.
  • a particular advantage for the dry, physical blends is that the ratio can be easily changed by simple blending techniques rather than manufacturing different ratios of a coprocessed material. Thus, the dry, physical blends provide great flexibility for specific applications having different requirements.
  • a dry, physical blend of microcrystalline cellulose and a film forming amount of propylene glycol alginate, a strengthening polymer, preferably, hydroxyethylcellulose (HEC), are present in the coating formulation of this invention, advantageously in combination with other optional ingredients such as a plasticizer, a surfactant, a filler or a coloring agent, other conventional excipients or combinations thereof.
  • HEC hydroxyethylcellulose
  • Other strengthening polymers which can provide the same benefit and may be used instead of HEC include HPMC, hydroxypropylcellulose, ethylcellulose, methylcellulose and polyvinylpyrrolidone (PVP), however care must be exercised in the use of such alternative materials to avoid retarding release of active ingredients and/or bioavailability.
  • the preferred amount of strengthening polymer is less than the total amount of microcrystalline cellulose and propylene glycol alginate present in the composition.
  • the strengthening polymer may be employed in the composition at a level of about 0.5% to about 30%, advantageously about 5% to 30% to provide strength and improved appearance to the coating.
  • This strength can be demonstrated by casting films of coating formulations on a flat, non-adherent surface, cutting strips of uniform width from the casting, and subjecting the strips to tensile testing on, for example, an Instron Tensile Tester. The results of these tests show a very significant increase in tensile strength and decreased brittleness of the film when HEC or another strengthening polymer is included in the formulation.
  • Strengthening polymers suitable for use in this invention are those polymers having a viscosity equal to or less than 20 mPa ⁇ s in a 2% aqueous solution at 20° C.
  • a strengthening polymer is employed in the composition in absence of a plasticizer, it is generally employed at about 15% to about 30% by dry weight coating composition, and HEC is preferably employed at about 20% to about 25% by dry weight of the formulation.
  • compositions of this invention may also contain at least one of a plasticizer, a surfactant, a filler, a coloring agent or a combination of these additional components of the composition.
  • a conventional plasticizer may also be included in the coating composition.
  • Suitable plasticizers include polyethylene glycol, triacetin, dibutyl sebacate, propylene glycol, sorbitol, glycerin, and triethyl citrate. Of these, triacetin is preferred.
  • These plasticizers may be employed in the coating compositions of the invention at about 18% to about 36% by dry weight of the coating composition, advantageously about 20% to about 30% by dry weight of the coating composition.
  • Fillers suitable for use in the compositions of the invention include, for example, calcium carbonate, dicalcium phosphate and carbohydrates, such as starch, maltodextrin, lactose, mannitol and other sugars or croscarmellose sodium. Of these, mannitol or maltodextrin is a preferred filler.
  • Surfactants which are either anionic or nonionic may be used beneficially in the edible, hardenable coating compositions of the present invention.
  • Useful surfactants may be, for example, sodium lauryl sulfate, hydroxylated soy lecithin, polysorbates, and block copolymers of propylene oxide and ethylene oxide.
  • Coloring agents and opacifiers which may be used in these coatings or added to a suspension thereof include aluminum lakes, insoluble pigments, water soluble dyes, titanium dioxide, and talc.
  • Stearic acid or a salt or ester thereof may be included at a level of about 1% to about 5% by dry weight of the compositions to increase gloss of the coating, particularly when a plasticizer is not employed in the composition.
  • a coating formulation of this invention may be sold as a dry powder formulation or as a ready-to-use dispersion in water.
  • aqueous dispersions it is preferred that these be prepared under aseptic conditions. Heating the water to an elevated temperature, for example, 85° C., prior to preparation of the dispersion has shown that bacteria, mold, and yeast growth are prevented for at least 48 hours on agar pour plates. Therefore, if the containers for the dispersion are properly sanitized and then kept closed after being filled until the dispersion is used, there is little likelihood of bacteria, mold, or yeast growing in the dispersion.
  • a preservative may be added.
  • a combination of methyl and/or propyl paraben has been found to be useful in this regard.
  • the composition of this invention comprises from about 15% to about 50% of microcrystalline cellulose, about 10% to about 50% by weight of propylene glycol alginate, and about 5% to about 25% of strengthening polymer. If a plasticizer is employed, it is advantageously used at about 20% to about 30% by weight of the composition.
  • the composition of the invention may also include an inert filler at about 2% to about 28% by weight.
  • about 1% to about 30% by weight of the formulation may comprise edible coloring agents and opacificiers such as talc or titanium dioxide, including from 1% to about 8% of coloring component such as a food dye or pigment, preferably about 1% to about 3%.
  • a surfactant at about 0.5% to about 10%, advantageously 0.5 to about 7%, preferably 1.25% to 3% when a filler such as mannitol is present.
  • a filler such as mannitol
  • surfactants such as lecithin may be employed at a level of about 3% to about 20%.
  • Preservatives such as methyl paraben at 0.75% to 1.50% and/or propyl paraben at 0.075% to 0.15% may also be present in the formulation.
  • the viscosity of the hydrated formulation can be important. It ideally should be low enough to be pumped to a spray unit continuously and then sprayed evenly in a useful pattern onto the substrate being coated.
  • a useful concentration of the dry ingredients in water on a weight percentage basis therefore, may be about 6% to about 15%, advantageously 6.5% to 11%, preferably about 8% to about 11%.
  • the preferred edible, hardenable, prompt release coating formulations of this invention may generally be prepared and used according to a simple procedure.
  • a dry blend of microcrystalline cellulose and propylene glycol alginate, and a strengthening polymer, such as hydroxyethylcellulose, and optionally at least one additional ingredient, such as polyethylene glycol or other acceptable plasticizer, optionally together with a solid filler such as maltodextrin, lactose, mannitol or the like, preservatives, and/or surfactants are blended to form dry coating composition.
  • Addition of edible coloring agents for example, a water soluble dye or a pigment, may precede the hydration step required to prepare the final coating formulation.
  • This dry mixture is then added slowly to the vortex of stirred, purified water. Stirring of this mixture is continued for a sufficient period to allow all of the components to be fully hydrated. If a colored coating material is required a water soluble dye or a pigment may also be added, preferably as a dispersion or solution, to the hydrated coating composition. Optionally surfactants, and/or plasticizers may also be added at this stage of the process.
  • a simple propeller mixer provides adequate agitation for rapid hydration.
  • the period of hydration may be as short as 0.5 hours. It may, and preferably should, be longer, but more than 3 hours is not believed to be necessary.
  • Hydration can take place at room temperature or at elevated temperatures as high as 65.5° C. (150° F.), preferably at a temperature about 48.9° C. (120° F.).
  • the time required for full hydration and the viscosity of the dispersion are both considerably reduced when the dispersion is prepared at an elevated temperature, but coating dispersions prepared at ambient temperature only require an increase in hydration time and a slight reduction in solids content to perform completely satisfactorily.
  • these formulations may be prepared on the day preceding the coating operation, if that is more convenient; however, a period of mixing will be required to overcome the thixotropic behavior of a formulation which sets up during overnight storage.
  • constant stirring of the microcrystalline and propylene glycol alginate-based formulations of this invention does not need to be continued throughout the coating procedure, but mixing may continue, if preferred.
  • Any commercial spray coater may be used to apply the coating.
  • useful coaters are Vector High Coaters manufactured by Vector Corporation and Accela-Cota manufactured by Thomas Engineering.
  • Equipment variables which one skilled in the art can manipulate to provide an elegant coating based on dry blends of microcrystalline cellulose and propylene glycol alginate, include inlet temperature, outlet temperature, air flow, speed of rotation of the coating pan, and the rate at which the coating formulation is pumped to the coater. It is important that the inlet and outlet temperatures be controlled so that they are high enough to efficiently dry the coating to prevent the tumbling action of the already-coated tablets from damaging the newly-applied coating before more coating is applied to the same tablets.
  • Hydroxyethylcellulose binds water more effectively than propylene glycol alginate does.
  • the presence of the major amount propylene glycol alginate in the formulations of this invention has a significant effect on the speed of drying of the edible coatings. Drying times are reduced considerably because of the presence of the propylene glycol alginate which dilutes the negative effect of HEC on drying time.
  • the outlet temperature can be reduced and still provide short enough drying time to be commercially useful.
  • Hydroxyethylcellulose is particularly susceptible to clogging spray nozzles at high temperatures.
  • An additional benefit provided by the formulations of this invention is the avoidance of clogging of the spray nozzles with dispersions being sprayed at high temperatures.
  • the level of coating applied to pharmaceutical or veterinary dosage forms is preferably between about 0.5% to about 4% by weight of the uncoated dosage form, more preferably about 2% to about 3.5%, by weight of the uncoated dosage form.
  • This level of coating will provide an elegant, serviceable coating to a wide variety of dosage forms. To apply a heavier coating to tablets would not be economical, and it might adversely affect disintegration of the tablets or other properties. Too light a coating would not provide optimal properties normally expected from a coating, for example, improved friability or adequate taste masking.
  • the coating level should be about 5% to about 10% by weight of the uncoated confection.
  • Seed coatings should be in the range of about 3% to about 6% by weight of the uncoated seeds.
  • Fertilizers and pesticide tablets and granules benefit from coating of 1% to about 3%, by weight of the uncoated granules or tablets.
  • the coatings of the present invention may be applied successfully to tablets having a wide variety of active ingredients incorporated therein.
  • active ingredients for example, it has been reported that multivitamin tablets are difficult to coat because of the lipophilic surface properties of the vitamins.
  • ibuprofen is a challenging active ingredient to coat. Tablets comprising both of these difficult-to-coat active ingredients have been coated readily with the instant invention, providing elegant tablets. Additionally, the coatings have been applied to tablets which have been debossed with letters or a logo without bridging which would hide, or even obliterate, the debossed design.
  • An additional utility of the coating formulations of this invention is as a replacement for sugar coating of tablets.
  • a sugar coating is applied primarily to increase the weight and/or size of the tablet, but this is an old art which presents numerous problems. It is, therefore, desirable to replace the traditional sugar coating with a more easily applied coating.
  • This coating procedure has the additional advantage that no topcoat is required to be applied as it is done with a sugar coating.
  • All components of the formulation are typically pharmaceutically acceptable, edible food grade materials.
  • a Vector High Coater LDCS was charged with 1 Kg of each of acetaminophen tablets and ibuprofen caplets.
  • the coater was operated at an inlet temperature of 84-85° C., an outlet temperature of 40-45° C., and 14-15 rpm.
  • a 3 weight percent coating based on the weight of the tablets & caplets was applied. Friability of the tablets and caplets was 0% after 10 minutes.
  • Example 1 By the method of Example 1, the dry components of each formulation were dry blended and dispersed in deionized water after which the triacetin and liquid components were added to the dispersion. The dispersion was then sprayed on caplets which were tested for friability.
  • Example 2 By the method of Example 1, the dry components of each formulation were dry blended then dispersed in deionized water. The dispersion was then hydrated and sprayed on caplets which were tested for friability, gloss and disintegration time. The examples are summarized in Table 3 below.

Abstract

An edible, hardenable coating composition is disclosed containing microcrystalline cellulose, a film forming amount of propylene glycol alginate, and a strengthening polymer, optionally in combination with at least one of a plasticizer, a surfactant, or a filler. The coating composition of the present invention may be applied to pharmaceutical and veterinary solid dosage forms, confectionery, seeds, animal feed, fertilizers, pesticide tablets, and foods and provides an elegant prompt release coating which-does not retard the release of active ingredients from the coated substrate.

Description

    RELATED APPLICATIONS
  • This application claims the benefit of prior Provisional Application Nos. 60/162,514, filed Oct. 29, 1999, 60/167,407, filed Nov. 24, 1999, 60/172,526, filed Dec. 17, 1999, 60/189,588, filed Mar. 15, 2000, and 60/217,499, filed Jul. 11, 2000.[0001]
  • FIELD OF THE INVENTION
  • This invention relates to edible, hardenable coating compositions comprising microcrystalline cellulose (MCC), a film forming amount of propylene glycol alginate (PGA) and a strengthening polymer, optionally containing a plasticizer, a surface active agent, a filler, a coloring agent or a combination of such optional ingredients. The coatings of the present invention can be applied to pharmaceutical, including neutraceutical, and veterinary solid dosage forms, such solid substrates such as seeds, animal feed, fertilizers, pesticide tablets and granules, and also to confectionery and foods. They are readily dispersed in aqueous media, and, when applied as a coating, provide high lustre coatings, which do not retard or extend release of active ingredient from a coated substrate. [0002]
  • BACKGROUND OF THE INVENTION
  • It is a common practice to coat pharmaceutical and veterinary tablets to obtain several advantages. Among these are to improve the surface characteristics of tablets to make them easier to swallow, to reduce the absorption of water or moisture which can potentially degrade the active ingredient or promote some other undesirable change in the tablet structure, and simply to make a more elegant appearing tablet. [0003]
  • Another very important function of a pharmaceutical or veterinary tablet coating is to improve the integrity of the tablet itself. Uncoated tablets are often subject to being abraded or chipped, causing a loss of active ingredient in the process. More dramatically, they may break into two or more pieces. One measure of a useful coating is its ability to prevent any of these physical degradations of tablet structure. The effectiveness of a coating material to prevent abrading, chipping, or breakage of the tablet is determined by friability testing. [0004]
  • Confectionery and foods may be coated with a formulation to preserve the confection or food from deteriorating by contact with the oxygen and the moisture in the atmosphere. Coatings also can provide improved appearance and desirable organoleptic properties to the food as well as preventing loss of flavor. [0005]
  • Seeds may be coated to preserve the viability of the seeds by protecting against moisture. They may also be coated as a means for increasing particle size to facilitate mechanical planting. A dye can be included in the coating formulation to identify the seeds as to quality, type, or some other designation. Frequently, a pesticide, e.g., a fungicide, is incorporated into the coating formulation to protect both the seed itself and the seedling that results from germination of the seed. In all cases, this coating must not decrease the viability of the seeds or interfere with germination when the seeds are planted in the soil. [0006]
  • Animal feed may be coated to improve its flowability, appearance and its resistance to powdering or dusting. In such applications, the coating may be formulated to include vitamins, hormones, antibiotics, or the like, to benefit the livestock which will consume the feed. [0007]
  • Fertilizers, in either granular or tableted forms, may be coated to retain the integrity of the form and, especially, to protect the fertilizer from moisture which can cause agglomeration during storage, which could make rapid, even application to the soil difficult or inconvenient. [0008]
  • Coating of tableted pesticide formulations serves to maintain the integrity of the tablets or granules until they are placed in water where they rapidly disintegrate, forming a solution or slurry to be applied to the soil or plants. A second, and equally important, function of the coatings on tablets containing pesticides is to prevent human contact with the pesticide, thereby increasing safety for those handling and applying the pesticide. [0009]
  • In the preparation of a coating formulation to be sprayed, the film-former is usually dissolved or dispersed in a solvent, for example, water, along with the other ingredients of the formulation. In aqueous systems, since many polymers require significant time to become fully hydrated, the coating formulation must frequently be prepared in advance of the time it is to be applied to the tablets. A common procedure is to prepare these coating formulations the day preceding the coating operation in order to assure adequate hydration of the polymers used in them. [0010]
  • A particular disadvantage of coatings based primarily on hydroxypropylmethylcellulose (HPMC) is that the coating may harden over time and therefore increase tablet disintegration times. An increase in disintegration time delays the bioavailability of the active ingredient at least in proportion to the increase in disintegration time. Many other agents commonly used in coating compositions are also known to delay release of pharmaceutical agents, such as enteric coatings which use polymeric film forming materials which are insoluble in water, or gastric fluid, some of these being specifically selected to by-pass both the stomach and small intestine and provide colonic release. [0011]
  • The coatings of this invention meet U.S. Pharmacopeia standards for rapid or immediate dissolution (U.S.P. monograph 23) of active ingredients from tablets or other solid dosage forms coated with them. They provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrates. Thus, they do not adversely impact or retard release of active ingredients from a substrate coated with them. Further, the coatings of this invention are readily dispersed and rapidly hydrated in aqueous media for application to a coating substrate, and provide elegant coatings which have all the benefits of coatings now in commercial use without the drawbacks that are common to them. [0012]
  • SUMMARY OF THE INVENTION
  • It has been found that these and other advantages may be achieved in accordance with the present invention by a coating composition which comprises a unique combination of materials specifically adapted for prompt release when placed in aqueous media or ingested. The coating composition of the present invention comprises microcrystalline cellulose, a film forming amount of propylene glycol alginate and a strengthening polymer, and may additionally contain a plasticizer, a surface active agent, a filler, a coloring agent or combination of these additional ingredients. More specifically, the present invention provides a prompt release, edible, hardenable coating composition, as well as dry coatings and aqueous dispersions thereof and solid dosage forms coated therewith. [0013]
  • DETAILED DESCRIPTION OF THE INVENTION
  • For purposes of this application, the term “edible” is intended to mean food grade materials which are approved by regulatory authorities for use in pharmaceutical or food applications. The term “hardenable,” used to describe the coating compositions of this invention, is intended to include only those coating compositions that are capable of being dried from an aqueous solution or dispersion thereof into a solid coating which resists abrasive forces, i.e. a hardened coating, as distinguished from those “enrobing” coatings on confections which set up into a soft coating that can be handled and packaged but which do not resist abrasive forces significantly. The terms “immediate,” “rapid,” or “prompt,” as applied to dissolution rates or times for the coating compositions of this invention or tablets coated with the compositions of this invention, mean that the coatings of this invention meet U.S. Pharmacopeia standards (U.S.P. monograph 23) for rapid or immediate dissolution of active ingredients from tablets or other solid dosage forms coated with them. Thus, they provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrate. They do not, when placed in water or ingested, adversely impact or retard release or dissolution of tablets or other dosage forms coated with them. Coatings made in accordance with the present invention are substantially or completely disintegrated and/or dissolved within less than 10 minutes after being ingested or placed in aqueous media. These definitions are intended to apply throughout this application unless a contrary meaning is clearly indicated. [0014]
  • The microcrystalline cellulose, simply blended with propylene glycol alginate, provides important film characteristics required to provide an elegant coating which is particularly useful in, for example, coating pharmaceutical and veterinary tablets, caplets, granules, and spheres which contain active ingredients which require release promptly after being placed in aqueous media or ingested. [0015]
  • Microcrystalline cellulose is a purified, partially depolymerized cellulose that is generally produced by treating a source of cellulose, preferably alpha cellulose in the form of a pulp from fibrous plants, with a mineral acid, preferably hydrochloric acid. The acid selectively attacks the less ordered regions of the cellulose polymer chain, thereby exposing and freeing the crystallite sites, forming the crystallite aggregates which constitute microcrystalline cellulose. These are then separated from the reaction mixture and washed to remove degraded by-products. The resulting wet mass, generally containing 40 to 60 [0016]
  • For purposes of this invention, a film forming amount of propylene glycol alginate may be in the range of about 10% to about 50%, more specifically about 12% to about 50%, by dry weight of the coating composition. The propylene glycol alginate employed in the present invention may vary widely in viscosity. A typical high viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 700 to 1800 mPa·s at 25° C., and is commercially available as Protonalg ester SD-LB, Pronova/FMC Corporation. A typical low viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 20-30 mPs·s at 25° C., and is commercially available as Profoam®, Pronova/FMC Corporation. [0017]
  • High viscosity propylene glycol alginate is generally employed in a lower amount than that employed for low viscosity material, typically in the range of 10% to about 20% by dry weight of the coating composition, as illustrated in examples 1-6 below. Use of substantially higher amounts of high viscosity propylene glycol alginate may result in coating solutions which are too viscous, tend to plug coating equipment, and may not flow sufficiently to form a satisfactory coating. Low viscosity propylene glycol alginate conversely is generally used in a higher amount, typically in the range of 20% to 50% by dry weight of the coating composition, as illustrated in examples 7 through 30. [0018]
  • Propylene glycol alginate may be used in combination with other film forming materials, for example, carrageenan and cellulosic polymers such as HPMC and hydroxypropylcellulose. [0019]
  • Carrageenan, preferably iota carrageenan, may suitably be employed as a multifunctional component in combination with propylene glycol alginate at a concentration in the range of about 3% to about 20% of the dry weight of the coating composition. When carrageenan is employed in the composition at a concentration in the range of about 3% to about 8%, it is believed to serve primarily to improve the gloss of the resulting coating, that is, as a gloss enhancer. When used for this purpose the weight ratio of propylene glycol alginate to carrageenan is suitably in the range of about 2:1 to about 10:1. [0020]
  • Carrageenan may also be used at a level above about 9%, for example, at a concentration in the range of about 9% to about 20%, more specifically in the range of 10% to about 15%. At these levels it is believed to serve not only to improve gloss of the coating, but also to contribute film forming properties and to contribute to the strength and integrity of the resulting film coating. Depending on the weight ratio of propylene glycol alginate to carrageenan, carrageenan may be viewed to function as a co-film-former or as a supplemental or secondary film-former in the coating compositions. Such a weight ratio of propylene glycol alginate to carrageenan may be in the range of 2:1 to about 0.8:1. For example, when the weight ratio of propylene glycol alginate to carrageenan is in the range of about 1.5:1 to about 2:1, propylene glycol alginate may be considered to be the primary film-former and carrageenan the secondary film-former, as illustrated in examples 18 through 21 and 25 through 30. When approximately equal amounts of propylene glycol alginate and carrageenan are employed, that is, when the propylene glycol alginate to carrageenan weight ratio is, for example, in the range of about 1:0.8 to about 1:1.2, each of them may be considered to contribute relatively equal film forming properties to the resulting film coating, thus are considered to be co-film-formers as illustrated by examples 18 and 20-24. [0021]
  • The weight ratio of microcrystalline cellulose to propylene glycol alginate in the compositions of this invention may vary depending on the application, but generally range from about 90:10 to about 20:80, more specifically from about 80:20 to about 20:80. A particular advantage for the dry, physical blends is that the ratio can be easily changed by simple blending techniques rather than manufacturing different ratios of a coprocessed material. Thus, the dry, physical blends provide great flexibility for specific applications having different requirements. [0022]
  • A dry, physical blend of microcrystalline cellulose and a film forming amount of propylene glycol alginate, a strengthening polymer, preferably, hydroxyethylcellulose (HEC), are present in the coating formulation of this invention, advantageously in combination with other optional ingredients such as a plasticizer, a surfactant, a filler or a coloring agent, other conventional excipients or combinations thereof. Other strengthening polymers which can provide the same benefit and may be used instead of HEC include HPMC, hydroxypropylcellulose, ethylcellulose, methylcellulose and polyvinylpyrrolidone (PVP), however care must be exercised in the use of such alternative materials to avoid retarding release of active ingredients and/or bioavailability. [0023]
  • The preferred amount of strengthening polymer is less than the total amount of microcrystalline cellulose and propylene glycol alginate present in the composition. Depending on the desired hardness of the coating, the strengthening polymer may be employed in the composition at a level of about 0.5% to about 30%, advantageously about 5% to 30% to provide strength and improved appearance to the coating. This strength can be demonstrated by casting films of coating formulations on a flat, non-adherent surface, cutting strips of uniform width from the casting, and subjecting the strips to tensile testing on, for example, an Instron Tensile Tester. The results of these tests show a very significant increase in tensile strength and decreased brittleness of the film when HEC or another strengthening polymer is included in the formulation. Strengthening polymers suitable for use in this invention, which will not retard release from tablets or other solid dosage forms, are those polymers having a viscosity equal to or less than 20 mPa·s in a 2% aqueous solution at 20° C. When a strengthening polymer is employed in the composition in absence of a plasticizer, it is generally employed at about 15% to about 30% by dry weight coating composition, and HEC is preferably employed at about 20% to about 25% by dry weight of the formulation. [0024]
  • In addition to the foregoing ingredients, the compositions of this invention may also contain at least one of a plasticizer, a surfactant, a filler, a coloring agent or a combination of these additional components of the composition. Thus, a conventional plasticizer may also be included in the coating composition. Suitable plasticizers include polyethylene glycol, triacetin, dibutyl sebacate, propylene glycol, sorbitol, glycerin, and triethyl citrate. Of these, triacetin is preferred. These plasticizers may be employed in the coating compositions of the invention at about 18% to about 36% by dry weight of the coating composition, advantageously about 20% to about 30% by dry weight of the coating composition. [0025]
  • Fillers suitable for use in the compositions of the invention include, for example, calcium carbonate, dicalcium phosphate and carbohydrates, such as starch, maltodextrin, lactose, mannitol and other sugars or croscarmellose sodium. Of these, mannitol or maltodextrin is a preferred filler. Surfactants which are either anionic or nonionic may be used beneficially in the edible, hardenable coating compositions of the present invention. Useful surfactants may be, for example, sodium lauryl sulfate, hydroxylated soy lecithin, polysorbates, and block copolymers of propylene oxide and ethylene oxide. Coloring agents and opacifiers which may be used in these coatings or added to a suspension thereof include aluminum lakes, insoluble pigments, water soluble dyes, titanium dioxide, and talc. Stearic acid or a salt or ester thereof, may be included at a level of about 1% to about 5% by dry weight of the compositions to increase gloss of the coating, particularly when a plasticizer is not employed in the composition. [0026]
  • A coating formulation of this invention may be sold as a dry powder formulation or as a ready-to-use dispersion in water. For aqueous dispersions it is preferred that these be prepared under aseptic conditions. Heating the water to an elevated temperature, for example, 85° C., prior to preparation of the dispersion has shown that bacteria, mold, and yeast growth are prevented for at least 48 hours on agar pour plates. Therefore, if the containers for the dispersion are properly sanitized and then kept closed after being filled until the dispersion is used, there is little likelihood of bacteria, mold, or yeast growing in the dispersion. Alternatively, if a formulation is to be sold as an aqueous dispersion to be stored for a period of time, a preservative may be added. A combination of methyl and/or propyl paraben has been found to be useful in this regard. [0027]
  • On a dry weight percentage basis the composition of this invention comprises from about 15% to about 50% of microcrystalline cellulose, about 10% to about 50% by weight of propylene glycol alginate, and about 5% to about 25% of strengthening polymer. If a plasticizer is employed, it is advantageously used at about 20% to about 30% by weight of the composition. The composition of the invention may also include an inert filler at about 2% to about 28% by weight. Optionally, about 1% to about 30% by weight of the formulation may comprise edible coloring agents and opacificiers such as talc or titanium dioxide, including from 1% to about 8% of coloring component such as a food dye or pigment, preferably about 1% to about 3%. Other optional ingredients may include a surfactant at about 0.5% to about 10%, advantageously 0.5 to about 7%, preferably 1.25% to 3% when a filler such as mannitol is present. When no filler is employed higher amounts of surfactants such as lecithin may be employed at a level of about 3% to about 20%. Preservatives, such as methyl paraben at 0.75% to 1.50% and/or propyl paraben at 0.075% to 0.15% may also be present in the formulation. [0028]
  • The low level of fillers present in these coating formulations, particularly when the opacifier is titanium dioxide, enables the formulator to utilize relatively small amounts of coloring agent. Since coloring agents are quite costly, this provides a significant cost reduction from those formulation requiring from 6% to about 16% to effectively color prior art coating formulations. [0029]
  • The viscosity of the hydrated formulation can be important. It ideally should be low enough to be pumped to a spray unit continuously and then sprayed evenly in a useful pattern onto the substrate being coated. A useful concentration of the dry ingredients in water on a weight percentage basis, therefore, may be about 6% to about 15%, advantageously 6.5% to 11%, preferably about 8% to about 11%. To assure uniformity of the coating composition, it may be preferable to maintain agitation of the aqueous dispersion during the entire period of its being sprayed onto the pharmaceutical or veterinary solid dosage forms, confectionery, seeds, animal feed, fertilizer, pesticide tablets, or food. [0030]
  • The preferred edible, hardenable, prompt release coating formulations of this invention may generally be prepared and used according to a simple procedure. A dry blend of microcrystalline cellulose and propylene glycol alginate, and a strengthening polymer, such as hydroxyethylcellulose, and optionally at least one additional ingredient, such as polyethylene glycol or other acceptable plasticizer, optionally together with a solid filler such as maltodextrin, lactose, mannitol or the like, preservatives, and/or surfactants are blended to form dry coating composition. Addition of edible coloring agents, for example, a water soluble dye or a pigment, may precede the hydration step required to prepare the final coating formulation. This dry mixture is then added slowly to the vortex of stirred, purified water. Stirring of this mixture is continued for a sufficient period to allow all of the components to be fully hydrated. If a colored coating material is required a water soluble dye or a pigment may also be added, preferably as a dispersion or solution, to the hydrated coating composition. Optionally surfactants, and/or plasticizers may also be added at this stage of the process. [0031]
  • In the formulations of microcrystalline cellulose and propylene glycol alginate, a simple propeller mixer provides adequate agitation for rapid hydration. The period of hydration may be as short as 0.5 hours. It may, and preferably should, be longer, but more than 3 hours is not believed to be necessary. Hydration can take place at room temperature or at elevated temperatures as high as 65.5° C. (150° F.), preferably at a temperature about 48.9° C. (120° F.). The time required for full hydration and the viscosity of the dispersion are both considerably reduced when the dispersion is prepared at an elevated temperature, but coating dispersions prepared at ambient temperature only require an increase in hydration time and a slight reduction in solids content to perform completely satisfactorily. As previously stated, these formulations may be prepared on the day preceding the coating operation, if that is more convenient; however, a period of mixing will be required to overcome the thixotropic behavior of a formulation which sets up during overnight storage. Unlike coating formulations based primarily on hydroxyalkyl ethers of cellulose, for example, HPMC, constant stirring of the microcrystalline and propylene glycol alginate-based formulations of this invention does not need to be continued throughout the coating procedure, but mixing may continue, if preferred. [0032]
  • Any commercial spray coater may be used to apply the coating. Examples of useful coaters are Vector High Coaters manufactured by Vector Corporation and Accela-Cota manufactured by Thomas Engineering. Equipment variables which one skilled in the art can manipulate to provide an elegant coating based on dry blends of microcrystalline cellulose and propylene glycol alginate, include inlet temperature, outlet temperature, air flow, speed of rotation of the coating pan, and the rate at which the coating formulation is pumped to the coater. It is important that the inlet and outlet temperatures be controlled so that they are high enough to efficiently dry the coating to prevent the tumbling action of the already-coated tablets from damaging the newly-applied coating before more coating is applied to the same tablets. [0033]
  • Hydroxyethylcellulose binds water more effectively than propylene glycol alginate does. Thus, the presence of the major amount propylene glycol alginate in the formulations of this invention has a significant effect on the speed of drying of the edible coatings. Drying times are reduced considerably because of the presence of the propylene glycol alginate which dilutes the negative effect of HEC on drying time. Thus, in the case of low melting active pharmaceutical agents, for example, ibuprofen, the outlet temperature can be reduced and still provide short enough drying time to be commercially useful. [0034]
  • Hydroxyethylcellulose is particularly susceptible to clogging spray nozzles at high temperatures. An additional benefit provided by the formulations of this invention is the avoidance of clogging of the spray nozzles with dispersions being sprayed at high temperatures. [0035]
  • The level of coating applied to pharmaceutical or veterinary dosage forms is preferably between about 0.5% to about 4% by weight of the uncoated dosage form, more preferably about 2% to about 3.5%, by weight of the uncoated dosage form. This level of coating will provide an elegant, serviceable coating to a wide variety of dosage forms. To apply a heavier coating to tablets would not be economical, and it might adversely affect disintegration of the tablets or other properties. Too light a coating would not provide optimal properties normally expected from a coating, for example, improved friability or adequate taste masking. [0036]
  • For confections the coating level should be about 5% to about 10% by weight of the uncoated confection. Seed coatings should be in the range of about 3% to about 6% by weight of the uncoated seeds. Fertilizers and pesticide tablets and granules benefit from coating of 1% to about 3%, by weight of the uncoated granules or tablets. [0037]
  • From the following examples is has been shown that the coatings of the present invention may be applied successfully to tablets having a wide variety of active ingredients incorporated therein. For example, it has been reported that multivitamin tablets are difficult to coat because of the lipophilic surface properties of the vitamins. Similarly, ibuprofen is a challenging active ingredient to coat. Tablets comprising both of these difficult-to-coat active ingredients have been coated readily with the instant invention, providing elegant tablets. Additionally, the coatings have been applied to tablets which have been debossed with letters or a logo without bridging which would hide, or even obliterate, the debossed design. [0038]
  • An additional utility of the coating formulations of this invention is as a replacement for sugar coating of tablets. A sugar coating is applied primarily to increase the weight and/or size of the tablet, but this is an old art which presents numerous problems. It is, therefore, desirable to replace the traditional sugar coating with a more easily applied coating. This coating procedure has the additional advantage that no topcoat is required to be applied as it is done with a sugar coating. [0039]
  • Storage of coated tablets under ambient temperature and humidity and 40° C. and 75% relative humidity for one to three months has demonstrated that no significant degradation has occurred. These tablets have disintegrated within the same length of time as the same batch of newly coated tablets did, and in each case provided dissolution rates and times substantially equal to those of the uncoated tablets used as a substrate for coating. This is an additional unexpected benefit of the coatings based on propylene glycol alginate and microcrystalline cellulose, and it differs from the known drawbacks of coating formulations in which HPMC is the primary or only film-former. [0040]
  • All components of the formulation are typically pharmaceutically acceptable, edible food grade materials. [0041]
  • The following examples, in which percentages are weight percent and tablet hardness is in Kiloponds (Kp), are provided to demonstrate the method of preparation and application of these elegant coatings, but they are not intended to be limiting as to amounts and the type of optional ingredients or the specific method of application of the tablet coating described herein.[0042]
  • EXAMPLE 1
  • In a Patterson-Kelly twin shell blender were placed 48.0 grams of a blend of microcrystalline cellulose (Avicel® PH-105, 35 grams) and propylene glycol alginate (13 grams), 20 grams of hydroxyethylcellulose (Aqualon®250L), 25 grams of triacetin, and 3 grams of Pluronic F-68 (BASF). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 1011.1 grams deionized water which was stirred with a Lightnin' mixer. The suspension was stirred for 2 hours at ambient temperature to fully hydrate the composition. To this dispersion was added 4.0 grams of red #40 liquid dispersion (Crompton and Knowles). A Vector High Coater LDCS was charged with 1 Kg of each of acetaminophen tablets and ibuprofen caplets. The coater was operated at an inlet temperature of 84-85° C., an outlet temperature of 40-45° C., and 14-15 rpm. During the spraying, which required 56 minutes, a 3 weight percent coating, based on the weight of the tablets & caplets was applied. Friability of the tablets and caplets was 0% after 10 minutes. [0043]
  • EXAMPLES 2 THROUGH 5
  • By the method of Example 1, the dry components of each formulation were dry blended and dispersed in deionized water after which the triacetin and liquid components were added to the dispersion. The dispersion was then sprayed on caplets which were tested for friability. These examples are summarized in Table 1 below: [0044]
    TABLE 1
    Example:
    2 3 4 5
    Ingredients Weight (grams)
    Avicel PH-105 37 35 37 37
    Hydroxyethyl- 22 20 22 22
    cellulose
    PGAa 13 13 12 12
    Pluronic F-68 3.5 3 1.5
    Red #40 24.5 4 6 7.5
    dispersion
    Triacetin 25
    Mannitolb 18 15
    Iota 5 5
    carrageenan
    Deionized 1011.1 1011.1 1011.1 1011.1
    water
    Hydration time 2 hours >1 hour 6 hours >1 hour
    Caplets Charge (Kg)
    Acetaminophen 0.67 1 0.67 0.67
    Ibuprofen 0.67 1 0.67 0.67
    Chlor- 0.67 0.67 0.67
    pheniramine
    Spray
    conditions
    Inlet 84-89° C. 83-85° C. 63-69° C. 69-74° C.
    temperature
    Outlet 36-40° C. 40-42° C. 38-39° C. 30-32° C.
    temperature
    Drum speed 14-15 rpm 15 rpm 11 rpm 10 rpm
    Time 54 minutes 57 minutes 55 minutes 58 minutes
    Coating 3 3 3 3
    weight (%)
    Friability
    (10 minutes)
    Acetaminophen 0% 0% 0% NT
    Ibuprofen 0% 0% slight NT
    Chlor- NTc NT NT
    pheniramine
  • EXAMPLE 6
  • The components of this example were dry blended. The dry blend was dispersed in deionized water, then sprayed on caplets and/or tablets which were tested for friability. This example is summarized in Table 2: [0045]
    TABLE 2
    Example:
    6
    Ingredients Weight (grams)
    Avicel PH-105 37
    PGAa 13
    Iota carrageenan 5
    Hydroxyethylcellulose 22
    Mannitolb 17.5
    Pluronic F-68 3.5
    Blue Lake #2 2
    Deionized water 1150
    Hydration time 2 hours
    Caplets Charge (Kg
    Ibuprofen 1
    Chlorpheniramine 1
    Spray conditions
    Inlet temperature 97-99° C.
    Outlet temperature 31-35° C.
    Drum speed 12-13 rpm
    Time 62 minutes
    Coating weight % 3%
    Friability (10 minutes)
    Ibuprofen 0%
    Chlorpheniramine 0%
  • EXAMPLES 7 -13
  • By the method of Example 1, the dry components of each formulation were dry blended then dispersed in deionized water. The dispersion was then hydrated and sprayed on caplets which were tested for friability, gloss and disintegration time. The examples are summarized in Table 3 below. [0046]
  • EXAMPLES 14-30
  • These additional examples were also prepared and applied in the manner of Examples 7-14. The resulting coating compositions are set forth in Table 4 below. [0047]
    TABLE 3
    Example
    7 8 9 10 11 12 13
    Ingredients Percentage by weight
    Avicel PH105 20 20 15 20 25 20 25
    PGAa 30 40 50 40 30 30 35
    HEC 20 10 5 15 15
    Lecithinb 3 3 3 3 3 3
    Maltodextrin M180 17 17 17 25 22 17 17
    Iota Carrageenan 5 5 5 5 5 5 5
    Red hydrophilic Iron Oxide 5 5 5 15 10
    Blue lake/Yellow lake blend 10
    % Solids 8 8 8 8 8 8 9
    Caplets Charged (Kg)
    Acetominophen 2 2 12 12 12 12 12
    Inlet Temperature (° C.) 78-88 67-90 46-53 50-53 52-54 52-54 67-72
    Exhaust Temperature (° C.) 35-41 29-36 33-36 32-38 32-36 34-36 30-35
    RPM 13 15 9 9 9 8 13
    Spray Rate (gm/ml) 12 19 55 66 72 67 11
    Time (minutes) 70 41 84 85 64 66 59
    Coating weight (%) 3 3 3 3 3 3 3
    Appearance (shine)d 5 4 4 2 3 4 4
    Friability (% - 10 minutes) 0 0 0 MCc MCc 0 0
    Disintegration Time, 37 ° C. (minutes) <5 <5 <5 <12 <5 <5 <5
  • [0048]
    TABLE 4
    Example:
    14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
    Ingredients (%) By Weight
    Avicel PH-105 25 20 25 20 34 25 20 20 25 25 25 25 25 22 25 25 25
    PGAa 35 35 35 30 13 26 25 25 13 13 13 20 18 26 20 15 20
    Hydroxyethylcellulose 15 15 17 20 22 22 20 20 20 20 20 17 15 20 15 20 20
    Iota carrageenan 5 5 5 5 12 12 12 12 15 15 15 12 12 12 12 10 10
    Lecithinb 3 3 5 3 7 3 3 3 7 7 5 7 3 7 3 5
    Maltodextrin 3 3 3 3 3 3 3 3 3 3 3 3 3 3
    PIGMENT (Var) 5 10 10 5 5 7 10 10 5 7 7 7 5 8 8 10 10
    Mannitolc 9 9 17 4 2 7 10 10 6 10 3
    Lactose 15
    Croscarmellose 5 3 5 3 5 3 2
    Calcium carbonate 7 7
    dicalcium Phosphate 5 11 5
    PVP 29/32, 25, s603

Claims (19)

What is claimed is:
1. An edible, hardenable, prompt release coating composition comprising (a) microcrystalline cellulose, (b) a film forming amount of propylene glycol alginate, (c) a strengthening polymer and optionally (d) at least one of a plasticizer, a surface active agent and a filler.
2. The coating composition of claim 1, comprising 5% to 50% by weight microcrystalline cellulose, 10% to 50% by weight propylene glycol alginate, and 5% to 25% by weight strengthening polymer.
3. The coating composition of claim 2, comprising 12% to 50% by weight propylene glycol alginate.
4. The coating composition of claim 1 in which the strengthening polymer is hydroxyethylcellulose.
5. The coating composition of claim 4, further comprising from 20% to 30% by weight plasticizer.
6. The coating composition of claim 5, in which the plasticizer is triacetin.
7. The coating composition of claim 4, further comprising from 1% to 5% by weight surface active agent.
8. The coating composition of claim 4, further comprising from 10% to 30% by weight of a filler.
9. The coating composition of claim 8, in which the filler is at least one of mannitol or maltodextrin.
10. The coating composition of claim 1, in which the weight ratio of microcrystalline cellulose to propylene glycol alginate is in the range of 90:10 to 20:80.
11. The coating composition of claim 1, wherein the microcrystalline cellulose has an average particle size in the range of 1 to 50 microns.
12. The coating composition of claim 10, further comprising carrageenan in an amount of from 3% to 20% by dry weight of the composition.
13. The coating composition of claim 12, wherein carrageenan is present in an amount in the range of 3% to 8% by dry weight of the composition and the weight ratio of propylene glycol alginate to carrageenan is in the range of 2:1 to 10:1
14. The composition of claim 12 wherein carrageenan is present in an amount in the range of 9% to 20% by dry weight of the composition and the weight ratio of propylene glycol alginate to carrageenan is in the range of 2:1 to 0.8:1.
15. The coating composition of claim 1, wherein said composition is a dry blend.
16. The coating composition of claim 1, wherein said composition is an aqueous dispersion.
17. The coating composition of claim 1 further comprising a coloring agent.
18. A solid dosage form coated with the composition of claim 1.
19. A method for forming an edible, hardenable, prompt release coating composition comprising
i) combining (a) microcrystalline cellulose, (b) a film forming amount of propylene glycol alginate, (c) a strengthening polymer and optionally (d) at least one of a plasticizer, a surface active agent and a filler; and
ii) forming a film coating by spraying an aqueous suspension of i) onto a substrate.
US10/306,649 1999-10-29 2002-11-27 Edible MCC/PGA coating composition Abandoned US20030129238A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/306,649 US20030129238A1 (en) 1999-10-29 2002-11-27 Edible MCC/PGA coating composition

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16251499P 1999-10-29 1999-10-29
US16740799P 1999-11-24 1999-11-24
US17252699P 1999-12-17 1999-12-17
US18958800P 2000-03-15 2000-03-15
US21749900P 2000-07-11 2000-07-11
US09/696,780 US6500462B1 (en) 1999-10-29 2000-10-26 Edible MCC/PGA coating composition
US10/306,649 US20030129238A1 (en) 1999-10-29 2002-11-27 Edible MCC/PGA coating composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/696,780 Continuation US6500462B1 (en) 1999-10-29 2000-10-26 Edible MCC/PGA coating composition

Publications (1)

Publication Number Publication Date
US20030129238A1 true US20030129238A1 (en) 2003-07-10

Family

ID=27558517

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/696,780 Expired - Fee Related US6500462B1 (en) 1999-10-29 2000-10-26 Edible MCC/PGA coating composition
US10/306,649 Abandoned US20030129238A1 (en) 1999-10-29 2002-11-27 Edible MCC/PGA coating composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/696,780 Expired - Fee Related US6500462B1 (en) 1999-10-29 2000-10-26 Edible MCC/PGA coating composition

Country Status (9)

Country Link
US (2) US6500462B1 (en)
EP (1) EP1223920A1 (en)
JP (1) JP2003514778A (en)
CN (1) CN1198600C (en)
AU (1) AU1443401A (en)
BR (1) BR0014965A (en)
IL (1) IL149149A0 (en)
TR (1) TR200201111T2 (en)
WO (1) WO2001032152A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026063A1 (en) * 2005-07-29 2007-02-01 Shin-Etsu Chemical Co., Ltd. Composition for coating comprising low-substituted cellulose ether and coated preparation having unpleasant taste masked
US20070128333A1 (en) * 2005-09-30 2007-06-07 Tuason Domingo C Stabilizers and Compositions and Products Comprising Same
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
US20080213360A1 (en) * 2006-10-27 2008-09-04 Fmc Corporation Dry granulation binders, products, and use thereof
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8801847B2 (en) 2002-05-14 2014-08-12 Fmc Corporation Microcrystalline cellulose compositions
US8927609B2 (en) 2011-12-09 2015-01-06 Fmc Corporation Co-attrited stabilizer composition
US9055757B2 (en) 2011-10-05 2015-06-16 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
US9826763B2 (en) 2011-10-05 2017-11-28 Fmc Corporation Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032150A1 (en) * 1999-10-29 2001-05-10 Fmc Corporation Edible coating composition
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
ES2204330B1 (en) * 2002-10-09 2005-03-01 La Morella Nuts, S.A. DRIED FRUIT COVERED WITH AN EDIBLE COATING FILM AND ITS OBTAINING.
JP2006524743A (en) * 2003-04-14 2006-11-02 エフ エム シー コーポレーション Uniform thermoreversible alginate film and soft capsule made therefrom
NZ545880A (en) * 2003-09-18 2008-07-31 Fmc Corp A method for dispersing metal oxides
GB2416473A (en) * 2004-07-22 2006-02-01 Mars Inc A confectionery product coated with a polymer film and method of manufacture
BRPI0515416A (en) * 2004-09-23 2008-07-22 Fmc Corp composition, solid form, film, and method for coating a solid form
US8088414B2 (en) 2006-02-07 2012-01-03 Fmc Corporation Latex or pseudolatex compositions, coatings and coating processes
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
WO2008140853A2 (en) * 2007-05-08 2008-11-20 Dow Global Technologies Inc. Water dispersible polymer compositions
US20100160363A1 (en) * 2008-12-19 2010-06-24 Aaipharma Services Corp. Extended-release pharmaceutical formulations
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
EP3038602A4 (en) 2013-08-28 2017-07-26 Sensient Colors LLC Edible coating compositions, edible coatings, and methods for making and using the same

Citations (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2881085A (en) * 1953-11-09 1959-04-07 Abbott Lab Thin film coating for tablets and the like
US3251824A (en) * 1961-08-22 1966-05-17 Fmc Corp Method of preparing stable aqueous dispersion-forming cellulosic aggregates
US3297535A (en) * 1963-02-28 1967-01-10 Hoffmann La Roche Shellac tablet coating compositions and methods of preparation
US3438797A (en) * 1965-10-21 1969-04-15 Jerry Allen Biddle Sr Method of preparing pharmaceutical tablets
US3503769A (en) * 1966-09-08 1970-03-31 Alginate Ind Ltd Method of modifying alkylene glycol alginates
US3573058A (en) * 1967-01-30 1971-03-30 Swift & Co Microcrystalline cellulose compositions co-dried with hydrocolloids
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3649302A (en) * 1969-11-10 1972-03-14 Cpc International Inc Process of producing a ready-to-spread frosting
US3860733A (en) * 1972-07-31 1975-01-14 Merck & Co Inc Microencapsulated product
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
US3883458A (en) * 1973-02-02 1975-05-13 Basf Ag Flatting agents for coatings
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US3957966A (en) * 1972-05-19 1976-05-18 Gaf Corporation Stabilized vitamin food coatings
US4009131A (en) * 1972-01-17 1977-02-22 The Lubrizol Corporation Powder coating compositions and metal objects coated therewith
US4015999A (en) * 1975-01-08 1977-04-05 Ciba-Geigy Corporation Pigment compositions
US4143163A (en) * 1976-06-30 1979-03-06 Maxfibe, Inc. Coated fibrous cellulose product and process
US4250195A (en) * 1979-09-24 1981-02-10 Life Savers, Inc. Method for applying soft flexible sugar coating to fresh chewing gum and coated chewing gum product
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4257816A (en) * 1979-09-17 1981-03-24 Merck & Co., Inc. Novel blend of algin, TKP, and guar gum
US4263334A (en) * 1978-05-31 1981-04-21 Fmc Corporation Water dispersible cellulosic powder and method of making the same
US4311717A (en) * 1980-05-19 1982-01-19 Fmc Corporation Stabilizing agent for dry mix food products
US4316884A (en) * 1979-01-25 1982-02-23 Adria Laboratories, Inc. Sustained release pharmaceutical formulation
US4324554A (en) * 1978-11-09 1982-04-13 Merck & Co., Inc. Use of TKP as an antimigrant
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
US4432966A (en) * 1979-12-10 1984-02-21 Roussel-Uclaf Compressed tablets for disintegration in the colon comprising an active ingredient containing nucleus coated with a first layer containing microcrystalline cellulose which is coated with an enteric organic polymer coating
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
US4513019A (en) * 1983-07-06 1985-04-23 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
US4636261A (en) * 1984-10-24 1987-01-13 Heinze Richard F Dry lake system
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4645662A (en) * 1984-07-26 1987-02-24 Lion Corporation Oral composition
US4652313A (en) * 1984-10-24 1987-03-24 Crompton And Knowles Corporation Aqueous lake pigment suspension
US4661162A (en) * 1983-04-18 1987-04-28 Sankyo Company, Limited Enteric-soluble preparations
US4666703A (en) * 1984-03-23 1987-05-19 Ciba-Geigy Corporation Storage-stable, quick-disintegrating pressed shapes containing pharmaceutical active substances
US4720378A (en) * 1981-03-09 1988-01-19 Imperial Chemical Industries Plc Coated colored intagliated articles
US4802924A (en) * 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816298A (en) * 1987-11-27 1989-03-28 The Dow Chemical Company Method of making a granular, cold water dispersible coating composition
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4892741A (en) * 1987-06-24 1990-01-09 Bayer Aktiengesellschaft Press coated DHP tablets
US4900557A (en) * 1984-08-30 1990-02-13 Troponwerke Gmbh & Co. Kg Pellet formulation
US4910028A (en) * 1985-03-06 1990-03-20 Griffith Laboratories U.S.A., Inc. Honey coated and honey glazed roasted nuts and method for producing same
US4913919A (en) * 1986-11-18 1990-04-03 Frito-Lay, Inc. Coating composition for comestible products
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4981707A (en) * 1987-03-24 1991-01-01 Ogilvie Mills, Inc. Dextrin-based food-grade adhesive including xanthan or carboxymethylcellulose or mixtures thereof
US4981698A (en) * 1986-12-23 1991-01-01 Warner-Lambert Co. Multiple encapsulated sweetener delivery system and method of preparation
US4983399A (en) * 1989-10-18 1991-01-08 Eastman Kodak Company Direct compression carrier composition
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5006513A (en) * 1987-11-09 1991-04-09 Miles Inc. Antimycotic compositions of nikkomycin compounds and azole antimycotica
US5008113A (en) * 1987-01-28 1991-04-16 Shin-Etsu Chemical Co., Ltd. Method for preparing film coated pharmaceutical preparations and method for improving properties thereof
US5008117A (en) * 1985-05-08 1991-04-16 Eurand Italia S.P.A. Formulation for preparing extemporaneous homogeneous microcapsule suspension
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5011701A (en) * 1988-12-30 1991-04-30 Kraft General Foods, Inc. Low calorie food products having smooth, creamy, organoleptic characteristics
US5082684A (en) * 1990-02-05 1992-01-21 Pfizer Inc. Low-calorie fat substitute
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
US5192569A (en) * 1989-05-26 1993-03-09 Fmc Corporation Fat-like bulking agent for aqueous foods comprising microcrystalline cellulose and a galactomannan gum
US5194464A (en) * 1988-09-27 1993-03-16 Takeda Chemical Industries, Ltd. Enteric film and preparatoin thereof
US5202129A (en) * 1989-08-04 1993-04-13 Tanabe Seiyaku Co., Ltd. Process for micronizing slightly-soluble drug
US5202137A (en) * 1990-06-29 1993-04-13 Berwind Pharmaceutical Services, Inc. Method of inhibiting fat and oil migration from an oily substrate of a food product into a coating layer of a food product
US5209942A (en) * 1991-11-27 1993-05-11 Thomas J. Lipton, Co., Division Of Conopco, Inc. Low fat/no fat salad dressing having mimetic functional properties fat and a process therefor
US5213738A (en) * 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5286502A (en) * 1992-04-21 1994-02-15 Wm. Wrigley Jr. Company Use of edible film to prolong chewing gum shelf life
US5286510A (en) * 1992-10-07 1994-02-15 Thomas J. Lipton Co., Division Of Conopco, Inc. Fat mimetic containing salad dressing and process therefor
US5288501A (en) * 1991-07-04 1994-02-22 Merz + Co. Gmbh & Co. Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients
US5306506A (en) * 1990-07-11 1994-04-26 Eurand International S.P.A. Pharmaceutical composition for rapid suspension in water
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US5389129A (en) * 1991-05-29 1995-02-14 Berwind Pharmaceutical Services, Inc. Wax polish composition
US5393333A (en) * 1990-03-27 1995-02-28 Societe Anonyme Societe D'exploitation De Produits Pour Les Industries Chimiques S.E.P.P.I.C. Film-forming product for coating solid forms, process for its manufacture and products coated with this film-forming product
US5411746A (en) * 1993-02-24 1995-05-02 Warner-Jenkinson Company, Inc. Dye compositions and methods for film coating tablets and the like
US5480479A (en) * 1990-12-20 1996-01-02 Warner-Jenkinson Company, Inc. Wet powder film-forming compositions
US5512092A (en) * 1994-04-15 1996-04-30 Shin-Etsu Chemical Co., Ltd. Method for preparing aqueous emulsion for coating solid pharmaceutical preparations
US5514435A (en) * 1993-03-10 1996-05-07 New Oji Paper Co., Ltd. Adhesive sheet
US5591455A (en) * 1990-12-20 1997-01-07 Warner-Jenkinson Company, Inc. Wet powder film-forming compositions
US5595762A (en) * 1992-11-30 1997-01-21 Laboratoires Virbac Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications
US5624612A (en) * 1993-08-25 1997-04-29 Fmc Corporation Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation
US5629003A (en) * 1990-06-07 1997-05-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Rapidly disintegrating sheet-like presentations of multiple dosage units
US5630871A (en) * 1991-01-17 1997-05-20 Berwind Pharmaceutical Services, Inc. Film coatings and film coating compositions based on cellulosic polymers and lactose
US5709896A (en) * 1996-06-18 1998-01-20 Fmc Corporation Reduced-fat food dispersions and method of preparing
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5741600A (en) * 1988-12-29 1998-04-21 Deknatel Technology Corporation, Inc. Absorbable coating and blend
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5876739A (en) * 1996-06-13 1999-03-02 Novartis Ag Insecticidal seed coating
US5882707A (en) * 1996-01-05 1999-03-16 Bpsi Holdings, Inc. Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
US5885617A (en) * 1994-07-12 1999-03-23 Bpsi Holdings, Inc. Moisture barrier film coating composition, method, and coated form
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
US6174529B1 (en) * 1991-06-21 2001-01-16 University Of Cincinnati Oral therapy for the treatment of allergies and method of manufacture
US6183808B1 (en) * 1997-01-06 2001-02-06 Bpsi Holdings, Inc. Film coatings and film coating compositions based on dextrin
US6348090B1 (en) * 1997-01-06 2002-02-19 Bpsi Holdings, Inc. Film coatings and film coating compositions based on dextrin

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB734414A (en) 1951-05-08 1955-08-03 Hercules Powder Co Ltd Improvements in or relating to preparation and use of finely-divided cellulose esters, ethers and mixed ether-esters
US4060598A (en) 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3906086A (en) 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
US3851574A (en) 1972-12-26 1974-12-03 Pillsbury Co Heat and moisture activated savory coating system for popcorn
US4112215A (en) 1975-03-20 1978-09-05 Rohm Gmbh Copolymeric resin binder powders
US4011392A (en) 1975-09-02 1977-03-08 The Sherwin-Williams Company Mixed starch esters and the use thereof
GB1594102A (en) 1977-09-26 1981-07-30 Sankyo Co Ingestible coating compositions
DE2820981C2 (en) 1977-09-27 1995-07-06 Colorcon Pharmaceutical tablet and method for coloring a pharmaceutical tablet
US4274830A (en) 1977-09-27 1981-06-23 Colorcon, Inc. Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products
US4336244A (en) 1977-09-27 1982-06-22 Colorcon, Inc. Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products
JPH027925B2 (en) 1978-10-02 1990-02-21 Purdue Research Foundation
US4307117A (en) 1980-03-27 1981-12-22 General Foods Corporation Stabilized curcumin colorant
US4340582A (en) 1981-01-15 1982-07-20 Abbott Laboratories Erythromycin base tablets
JPS57171428A (en) 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
US4790881A (en) 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
US4514384A (en) 1983-03-14 1985-04-30 Gallina Damian J Hemorrhoid treatment method
DK62184D0 (en) 1984-02-10 1984-02-10 Benzon As Alfred DIFFUSION COATED POLYDEPOT PREPARATION
CA1239034A (en) 1984-08-17 1988-07-12 Kelly L. Smith Delivery system
EP0181966A1 (en) 1984-11-13 1986-05-28 Gist-Brocades N.V. Compression-coated dispersible tablets
DE3506276C1 (en) 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direct tableting
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
JPH0780754B2 (en) 1986-08-06 1995-08-30 エーザイ株式会社 Multi-granular sustained-release tablet
US4735659A (en) 1986-08-18 1988-04-05 Phillips Petroleum Company Compositions and a process for preparing water dispersible polymers
US4959227A (en) 1987-02-17 1990-09-25 Amer Moh S High dietary fiber low lactose liquid food and a method of producing same
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US4792452A (en) 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5023083A (en) 1987-09-23 1991-06-11 William Drell Azarbine composition
US5068110A (en) 1987-09-29 1991-11-26 Warner-Lambert Company Stabilization of enteric coated dosage form
GB2212396A (en) 1987-12-18 1989-07-26 Procter & Gamble Dietary supplement comprising calcium and delayed release coated iron
US5472710A (en) 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
US4931285A (en) 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US5006362A (en) 1988-05-09 1991-04-09 Berwind Pharmaceutical Services, Inc. Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US4877629A (en) 1988-06-10 1989-10-31 International Flavors & Fragrances Inc. Process for preparing a coated food product
US5268182A (en) 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
IE63242B1 (en) 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
US5169639A (en) 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
FR2653337B1 (en) 1989-10-23 1992-02-07 Dow Corning Sa SUSTAINED RELEASE ELEMENT AND METHOD FOR MANUFACTURING THE SAME.
JP2646851B2 (en) 1989-10-26 1997-08-27 日本新薬株式会社 Gastric retention formulation
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
JP3078859B2 (en) 1990-02-23 2000-08-21 武田薬品工業株式会社 Coating agent for stable controlled release formulation
US5368840A (en) 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
IT1246382B (en) 1990-04-17 1994-11-18 Eurand Int METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON
WO1992012633A1 (en) 1991-01-16 1992-08-06 Fmc Corporation Carrier for active agents, and solid dosage forms prepared therewith
HU209564B (en) 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
GB2253164B (en) 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
US5332595A (en) * 1991-03-18 1994-07-26 Kraft General Foods, Inc. Stable multiple emulsions comprising interfacial gelatinous layer, flavor-encapsulating multiple emulsions and low/no-fat food products comprising the same
KR100221695B1 (en) 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 Pharmaceutical spheroid formulation
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5472712A (en) 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
DE4200821A1 (en) 1992-01-15 1993-07-22 Bayer Ag TASTE-MASKED PHARMACEUTICAL AGENTS
US5262173A (en) 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
IT1255522B (en) 1992-09-24 1995-11-09 Ubaldo Conte COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS
IT1265092B1 (en) 1993-05-31 1996-10-30 Giuliani Spa PREPARATION FOR USE AS A FOOD OR DIETARY SUPPLEMENT WITH TARGETED RELEASE IN THE COLON
KR100337985B1 (en) 1993-06-14 2002-11-23 얀센 파마슈티카 엔.브이. Extended release film-coated tablet of astemizole and pseudoephedrine
JP3017906B2 (en) 1993-10-08 2000-03-13 信越化学工業株式会社 Enteric coating agent dispersion
FR2711525B1 (en) 1993-10-29 1996-01-12 Virbac Laboratoires Galenic form for oral administration for animals, its preparation process and its applications.
EP0746310B1 (en) 1994-02-23 1998-11-18 BM Research A/S Controlled release composition
US5458887A (en) 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
HU212428B (en) 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
US5523293A (en) 1994-05-25 1996-06-04 Iowa State University Research Foundation, Inc. Soy protein-based thermoplastic composition for preparing molded articles
US5529783A (en) 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
KR100201352B1 (en) 1995-03-16 1999-06-15 성재갑 Single shot vaccine formulation
JP3149125B2 (en) 1995-05-01 2001-03-26 信越化学工業株式会社 Base for coating solid enteric preparations
US5840332A (en) 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
IT1282650B1 (en) 1996-02-19 1998-03-31 Jagotec Ag PHARMACEUTICAL TABLET, CHARACTERIZED BY A HIGH INCREASE IN VOLUME IN CONTACT WITH BIOLOGICAL LIQUIDS
US5849320A (en) 1996-06-13 1998-12-15 Novartis Corporation Insecticidal seed coating
FR2750864B1 (en) 1996-07-10 1999-04-16 Oreal USE OF A POLYHOLOSIDE IN A COMPOSITION FOR STIMULATING IMMUNE DEFENSES, AND COMPOSITION COMPRISING SAME
EP0852141A1 (en) 1996-08-16 1998-07-08 J.B. Chemicals &amp; Pharmaceuticals Ltd. Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof
US5662732A (en) 1996-08-09 1997-09-02 Bpsi Holdings, Inc. Polish composition
US5851579A (en) 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
US5807580A (en) 1996-10-30 1998-09-15 Mcneil-Ppc, Inc. Film coated tablet compositions having enhanced disintegration characteristics
ES2137862B1 (en) 1997-07-31 2000-09-16 Intexim S A ORAL PHARMACEUTICAL PREPARATION INCLUDING A COMPOUND OF ANTI-ULCER ACTIVITY AND PROCEDURE FOR ITS OBTAINING.
NZ511442A (en) * 1998-11-02 2003-02-28 Elan Corp Plc Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
US6274162B1 (en) 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2881085A (en) * 1953-11-09 1959-04-07 Abbott Lab Thin film coating for tablets and the like
US3251824A (en) * 1961-08-22 1966-05-17 Fmc Corp Method of preparing stable aqueous dispersion-forming cellulosic aggregates
US3297535A (en) * 1963-02-28 1967-01-10 Hoffmann La Roche Shellac tablet coating compositions and methods of preparation
US3438797A (en) * 1965-10-21 1969-04-15 Jerry Allen Biddle Sr Method of preparing pharmaceutical tablets
US3503769A (en) * 1966-09-08 1970-03-31 Alginate Ind Ltd Method of modifying alkylene glycol alginates
US3573058A (en) * 1967-01-30 1971-03-30 Swift & Co Microcrystalline cellulose compositions co-dried with hydrocolloids
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US3649302A (en) * 1969-11-10 1972-03-14 Cpc International Inc Process of producing a ready-to-spread frosting
US4009131A (en) * 1972-01-17 1977-02-22 The Lubrizol Corporation Powder coating compositions and metal objects coated therewith
US3957966A (en) * 1972-05-19 1976-05-18 Gaf Corporation Stabilized vitamin food coatings
US3860733A (en) * 1972-07-31 1975-01-14 Merck & Co Inc Microencapsulated product
US3883458A (en) * 1973-02-02 1975-05-13 Basf Ag Flatting agents for coatings
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
US4015999A (en) * 1975-01-08 1977-04-05 Ciba-Geigy Corporation Pigment compositions
US4143163A (en) * 1976-06-30 1979-03-06 Maxfibe, Inc. Coated fibrous cellulose product and process
US4263334A (en) * 1978-05-31 1981-04-21 Fmc Corporation Water dispersible cellulosic powder and method of making the same
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4324554A (en) * 1978-11-09 1982-04-13 Merck & Co., Inc. Use of TKP as an antimigrant
US4316884A (en) * 1979-01-25 1982-02-23 Adria Laboratories, Inc. Sustained release pharmaceutical formulation
US4257816A (en) * 1979-09-17 1981-03-24 Merck & Co., Inc. Novel blend of algin, TKP, and guar gum
US4250195A (en) * 1979-09-24 1981-02-10 Life Savers, Inc. Method for applying soft flexible sugar coating to fresh chewing gum and coated chewing gum product
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4432966A (en) * 1979-12-10 1984-02-21 Roussel-Uclaf Compressed tablets for disintegration in the colon comprising an active ingredient containing nucleus coated with a first layer containing microcrystalline cellulose which is coated with an enteric organic polymer coating
US4311717A (en) * 1980-05-19 1982-01-19 Fmc Corporation Stabilizing agent for dry mix food products
US4720378A (en) * 1981-03-09 1988-01-19 Imperial Chemical Industries Plc Coated colored intagliated articles
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
US4661162A (en) * 1983-04-18 1987-04-28 Sankyo Company, Limited Enteric-soluble preparations
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
US4513019A (en) * 1983-07-06 1985-04-23 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
US4665648A (en) * 1983-07-06 1987-05-19 Seppic Sa Film-forming compositions for enveloping grains and seeds
US4666703A (en) * 1984-03-23 1987-05-19 Ciba-Geigy Corporation Storage-stable, quick-disintegrating pressed shapes containing pharmaceutical active substances
US4725441A (en) * 1984-07-24 1988-02-16 Colorcon, Inc. Maltodextrin coating
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4645662A (en) * 1984-07-26 1987-02-24 Lion Corporation Oral composition
US4900557A (en) * 1984-08-30 1990-02-13 Troponwerke Gmbh & Co. Kg Pellet formulation
US4652313A (en) * 1984-10-24 1987-03-24 Crompton And Knowles Corporation Aqueous lake pigment suspension
US4636261A (en) * 1984-10-24 1987-01-13 Heinze Richard F Dry lake system
US4910028A (en) * 1985-03-06 1990-03-20 Griffith Laboratories U.S.A., Inc. Honey coated and honey glazed roasted nuts and method for producing same
US5008117A (en) * 1985-05-08 1991-04-16 Eurand Italia S.P.A. Formulation for preparing extemporaneous homogeneous microcapsule suspension
US4802924A (en) * 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
US4913919A (en) * 1986-11-18 1990-04-03 Frito-Lay, Inc. Coating composition for comestible products
US4981698A (en) * 1986-12-23 1991-01-01 Warner-Lambert Co. Multiple encapsulated sweetener delivery system and method of preparation
US5008113A (en) * 1987-01-28 1991-04-16 Shin-Etsu Chemical Co., Ltd. Method for preparing film coated pharmaceutical preparations and method for improving properties thereof
US5401515A (en) * 1987-02-03 1995-03-28 Dow Corning Corporation Coated active agent-containing article
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US4981707A (en) * 1987-03-24 1991-01-01 Ogilvie Mills, Inc. Dextrin-based food-grade adhesive including xanthan or carboxymethylcellulose or mixtures thereof
US4892741A (en) * 1987-06-24 1990-01-09 Bayer Aktiengesellschaft Press coated DHP tablets
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US5006513A (en) * 1987-11-09 1991-04-09 Miles Inc. Antimycotic compositions of nikkomycin compounds and azole antimycotica
US4816298A (en) * 1987-11-27 1989-03-28 The Dow Chemical Company Method of making a granular, cold water dispersible coating composition
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5194464A (en) * 1988-09-27 1993-03-16 Takeda Chemical Industries, Ltd. Enteric film and preparatoin thereof
US5741600A (en) * 1988-12-29 1998-04-21 Deknatel Technology Corporation, Inc. Absorbable coating and blend
US5011701A (en) * 1988-12-30 1991-04-30 Kraft General Foods, Inc. Low calorie food products having smooth, creamy, organoleptic characteristics
US5192569A (en) * 1989-05-26 1993-03-09 Fmc Corporation Fat-like bulking agent for aqueous foods comprising microcrystalline cellulose and a galactomannan gum
US5202129A (en) * 1989-08-04 1993-04-13 Tanabe Seiyaku Co., Ltd. Process for micronizing slightly-soluble drug
US4983399A (en) * 1989-10-18 1991-01-08 Eastman Kodak Company Direct compression carrier composition
US5082684A (en) * 1990-02-05 1992-01-21 Pfizer Inc. Low-calorie fat substitute
US5393333A (en) * 1990-03-27 1995-02-28 Societe Anonyme Societe D'exploitation De Produits Pour Les Industries Chimiques S.E.P.P.I.C. Film-forming product for coating solid forms, process for its manufacture and products coated with this film-forming product
US5213738A (en) * 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5629003A (en) * 1990-06-07 1997-05-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Rapidly disintegrating sheet-like presentations of multiple dosage units
US5202137A (en) * 1990-06-29 1993-04-13 Berwind Pharmaceutical Services, Inc. Method of inhibiting fat and oil migration from an oily substrate of a food product into a coating layer of a food product
US5306506A (en) * 1990-07-11 1994-04-26 Eurand International S.P.A. Pharmaceutical composition for rapid suspension in water
US5480479A (en) * 1990-12-20 1996-01-02 Warner-Jenkinson Company, Inc. Wet powder film-forming compositions
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
US5591455A (en) * 1990-12-20 1997-01-07 Warner-Jenkinson Company, Inc. Wet powder film-forming compositions
US5514384A (en) * 1990-12-20 1996-05-07 Warner-Jenkins Co. Wet powder film-forming compositions
US5630871A (en) * 1991-01-17 1997-05-20 Berwind Pharmaceutical Services, Inc. Film coatings and film coating compositions based on cellulosic polymers and lactose
US5743947A (en) * 1991-01-17 1998-04-28 Berwind Pharmaceutical Services, Inc. Film coatings and film coating compositions based on cellulosic polymers and lacttose
US5389129A (en) * 1991-05-29 1995-02-14 Berwind Pharmaceutical Services, Inc. Wax polish composition
US6174529B1 (en) * 1991-06-21 2001-01-16 University Of Cincinnati Oral therapy for the treatment of allergies and method of manufacture
US5288501A (en) * 1991-07-04 1994-02-22 Merz + Co. Gmbh & Co. Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients
US5209942A (en) * 1991-11-27 1993-05-11 Thomas J. Lipton, Co., Division Of Conopco, Inc. Low fat/no fat salad dressing having mimetic functional properties fat and a process therefor
US5409715A (en) * 1992-04-21 1995-04-25 Wm. Wrigley Jr. Company Use of edible film to prolong chewing gum shelf life
US5286502A (en) * 1992-04-21 1994-02-15 Wm. Wrigley Jr. Company Use of edible film to prolong chewing gum shelf life
US5286510A (en) * 1992-10-07 1994-02-15 Thomas J. Lipton Co., Division Of Conopco, Inc. Fat mimetic containing salad dressing and process therefor
US5595762A (en) * 1992-11-30 1997-01-21 Laboratoires Virbac Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications
US5595592A (en) * 1993-02-24 1997-01-21 Warner-Jenkinson Company, Inc. Dye compositions and methods for film coating tablets and the like
US5512314A (en) * 1993-02-24 1996-04-30 Warner-Jenkinson Company Dye compositions and methods for film coating tablets and the like
US5411746A (en) * 1993-02-24 1995-05-02 Warner-Jenkinson Company, Inc. Dye compositions and methods for film coating tablets and the like
US5514435A (en) * 1993-03-10 1996-05-07 New Oji Paper Co., Ltd. Adhesive sheet
US5624612A (en) * 1993-08-25 1997-04-29 Fmc Corporation Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation
US5512092A (en) * 1994-04-15 1996-04-30 Shin-Etsu Chemical Co., Ltd. Method for preparing aqueous emulsion for coating solid pharmaceutical preparations
US5885617A (en) * 1994-07-12 1999-03-23 Bpsi Holdings, Inc. Moisture barrier film coating composition, method, and coated form
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US6039976A (en) * 1994-10-07 2000-03-21 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5882707A (en) * 1996-01-05 1999-03-16 Bpsi Holdings, Inc. Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
US5876739A (en) * 1996-06-13 1999-03-02 Novartis Ag Insecticidal seed coating
US5709896A (en) * 1996-06-18 1998-01-20 Fmc Corporation Reduced-fat food dispersions and method of preparing
US6183808B1 (en) * 1997-01-06 2001-02-06 Bpsi Holdings, Inc. Film coatings and film coating compositions based on dextrin
US6348090B1 (en) * 1997-01-06 2002-02-19 Bpsi Holdings, Inc. Film coatings and film coating compositions based on dextrin
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8801847B2 (en) 2002-05-14 2014-08-12 Fmc Corporation Microcrystalline cellulose compositions
US8636011B2 (en) 2003-11-07 2014-01-28 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US10945454B2 (en) 2003-11-07 2021-03-16 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US10765140B2 (en) 2003-11-07 2020-09-08 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US10098376B2 (en) 2003-11-07 2018-10-16 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US20070026063A1 (en) * 2005-07-29 2007-02-01 Shin-Etsu Chemical Co., Ltd. Composition for coating comprising low-substituted cellulose ether and coated preparation having unpleasant taste masked
US8795722B2 (en) 2005-07-29 2014-08-05 Shin-Etsu Chemical Co., Ltd. Composition for coating comprising low-substituted cellulose ether and coated preparation having unpleasant taste masked
US7879382B2 (en) 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
US20070128333A1 (en) * 2005-09-30 2007-06-07 Tuason Domingo C Stabilizers and Compositions and Products Comprising Same
WO2007087188A3 (en) * 2006-01-20 2007-12-13 Merck & Co Inc Taste-masked tablets and granules
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
US7998505B2 (en) 2006-10-27 2011-08-16 Fmc Corporation Dry granulation binders, products, and use thereof
US20080213360A1 (en) * 2006-10-27 2008-09-04 Fmc Corporation Dry granulation binders, products, and use thereof
US9055757B2 (en) 2011-10-05 2015-06-16 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
US9826763B2 (en) 2011-10-05 2017-11-28 Fmc Corporation Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
US10299501B2 (en) 2011-10-05 2019-05-28 DuPont Nutrition USA, Inc. Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
US8927609B2 (en) 2011-12-09 2015-01-06 Fmc Corporation Co-attrited stabilizer composition
US9828493B2 (en) 2011-12-09 2017-11-28 Fmc Corporation Co-attrited stabilizer composition having superior gel strength

Also Published As

Publication number Publication date
CN1384737A (en) 2002-12-11
JP2003514778A (en) 2003-04-22
TR200201111T2 (en) 2003-01-21
BR0014965A (en) 2002-10-01
US6500462B1 (en) 2002-12-31
AU1443401A (en) 2001-05-14
IL149149A0 (en) 2002-11-10
WO2001032152A1 (en) 2001-05-10
EP1223920A1 (en) 2002-07-24
CN1198600C (en) 2005-04-27

Similar Documents

Publication Publication Date Title
US6500462B1 (en) Edible MCC/PGA coating composition
US6709713B2 (en) Edible coating composition
US6932861B2 (en) Edible PGA coating composition
US6723342B1 (en) Edible coating composition
US6699315B2 (en) Edible PGA coating composition
US8123849B2 (en) Aqueous film coating composition containing sodium alginate and preparation thereof
WO2001032150A1 (en) Edible coating composition
US20050196445A1 (en) Edible microcrystalline cellulose and carrageenan coating composition
MXPA01007782A (en) Edible coating composition

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION